Papachristou D N, Liu J L, Patel Y C
Fraser Laboratories, Department of Medicine, McGill University, Royal Victoria Hospital, Montreal, Quebec, Canada.
Endocrinology. 1994 May;134(5):2259-66. doi: 10.1210/endo.134.5.7908873.
Although a number of previous studies have suggested that glucocorticoids influence somatostatin (SS) function at the peptide level in some tissues and SS mRNA levels in thyroid tumor cells, there has been no systematic investigation of the effects of glucocorticoids on SS gene expression in normal tissues. In the present study, we have examined the effect of dexamethasone (DEX) on SS secretion and gene expression in rat tissues using as models DEX-treated rats in vivo, primary cultures of rat islet and cerebrocortical cells, and a SS-producing rat islet tumor cell line (1027B2). In vivo DEX administration (0.5 mg/kg) for 3 or 8 days augmented SS-mRNA 2- to 3-fold in peripheral tissues (stomach, pancreas, and jejunum), but reduced it by 50-60% in brain. The DEX effect was time dependent, being more pronounced after 8 days than after 3 days of treatment. In all tissues, SS mRNA levels returned to control values 2 weeks after cessation of DEX. Changes in tissue content of immunoreactive SS paralleled those in SS mRNA. In cultured rat islet cells, 18-h incubation with DEX induced dose-dependent biphasic effects on immunoreactive SS and SS mRNA; low doses (10(-10) M) were stimulatory, and high doses (10(-8)-10(-5) M) were inhibitory. Insulin secretion displayed dose-dependent stimulation by DEX, whereas glucagon release was inhibited. The effect of DEX on SS mRNA levels in primary cultures of brain cells was solely inhibitory. 1027B2 cells responded to DEX with augmented immunoreactive SS secretion and SS mRNA levels at low concentration (10(-10) M), followed by a dose-dependent inhibition of both parameters with increasing DEX concentrations. We conclude that glucocorticoids exert significant effects on SS peptide production and steady state mRNA levels in normal SS-producing tissues in vivo, in vitro, and in cultured 1027B2 cells. The glucocorticoid effect is time and dose dependent, tissue specific, and at least in part due to a direct action of the steroid hormone on SS-producing cells.
尽管先前的一些研究表明,糖皮质激素在某些组织中会在肽水平上影响生长抑素(SS)的功能,并影响甲状腺肿瘤细胞中SS mRNA的水平,但尚未对糖皮质激素对正常组织中SS基因表达的影响进行系统研究。在本研究中,我们以体内经地塞米松(DEX)处理的大鼠、大鼠胰岛和大脑皮质细胞的原代培养物以及一株产生SS的大鼠胰岛肿瘤细胞系(1027B2)为模型,研究了地塞米松(DEX)对大鼠组织中SS分泌和基因表达的影响。在体内给予DEX(0.5mg/kg)3天或8天,可使外周组织(胃、胰腺和空肠)中的SS-mRNA增加2至3倍,但使脑中的SS-mRNA减少50 - 60%。DEX的作用具有时间依赖性,治疗8天后比3天后更明显。在所有组织中,停止使用DEX 2周后,SS mRNA水平恢复到对照值。免疫反应性SS的组织含量变化与SS mRNA的变化平行。在培养的大鼠胰岛细胞中,与DEX一起孵育18小时对免疫反应性SS和SS mRNA产生剂量依赖性的双相效应;低剂量(10^(-10)M)具有刺激作用,高剂量(10^(-8)-10^(-5)M)具有抑制作用。胰岛素分泌表现出DEX剂量依赖性的刺激作用,而胰高血糖素释放受到抑制。DEX对脑细胞原代培养物中SS mRNA水平的影响完全是抑制性的。1027B2细胞在低浓度(10^(-10)M)时对DEX的反应是免疫反应性SS分泌和SS mRNA水平增加,随后随着DEX浓度的增加,这两个参数均受到剂量依赖性的抑制。我们得出结论,糖皮质激素在体内、体外以及培养的1027B2细胞中,对正常产生SS的组织中的SS肽产生和稳态mRNA水平具有显著影响。糖皮质激素的作用具有时间和剂量依赖性、组织特异性,并且至少部分是由于类固醇激素对产生SS的细胞的直接作用。